The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase

The solution structure of HIV-1 Nef has been solved by multidimensional heteronuclear NMR spectroscopy. The construct employed to circumvent problems associated with aggregation was a double-deletion mutant (2−39, 159−173) in which conformationally disordered regions of the protein at the N terminus and in a long solvent-exposed flexible loop were removed, without affecting the properties or structural integrity of the remainder of the protein. Despite the absence of any sequence similarity, the overall fold of Nef is reminiscent of that of the family of winged helix-turn-helix DNA binding proteins. The binding surface of Nef for the SH3 domain of Hck tyrosine protein kinase has been mapped and reveals a non-contiguous (in terms of amino-acid sequence) interaction surface. This unique feature may suggest possible avenues for drug design aimed at inhibiting the interaction between Nef and SH3 domains.

1. Shugars, D.C. et al. Analysis of human immunodeficiency virus type 1 nef Gene sequences present in vivo. J. Virol. 67, 4639−4650 (1993). | PubMed | ISI | ChemPort |
2. Kestler, H.W. et al. Importance of the Nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651−662 (1991). | Article | PubMed | ISI | ChemPort |
3. Kirchhoff, F., Greenhough, T.C., Brettler, D.B., Sullivan, J.L. & Desrosiers, R.C. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228−232 (1995). | Article | PubMed | ISI | ChemPort |
4. Deacon, N.J. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988−991 (1995). | PubMed | ISI | ChemPort |
5. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Seghal, P.K. & Desrosiers, R.C. Protective effects of live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938−1941 (1992). | PubMed | ISI | ChemPort |
6. Cullen, B.R. The role of Nef in the replication cycle of the human and Simian immunodeficiency viruses. Virology 205, 1−6 (1994). | Article | PubMed | ISI | ChemPort |
7. Goldsmith, M.A., Warmerdam, M.T., Atchison, R.E., Miller, M.D. & Greene, W.C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112−4121 (1995). | ChemPort |
8. Salghetti, S., Mariani, R. & Skowronski, J. Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl. Acad. Sci. USA 92, 349−353 (1995). | PubMed | ChemPort |
9. Greenway, A., Azad, A. & McPhee, D. Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842−1850 (1995). | PubMed | ISI | ChemPort |
10. Saksela, K., Cheng, G. & Baltimore, D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484−491 (1995). | PubMed | ISI | ChemPort |
11. Lee, C.-H. et al. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14, 5006−5015 (1995). | PubMed | ISI | ChemPort |
12. Scjwartz. O., Marechal, V., Danos, O. & Heard, J.M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053−4059 (1995). | PubMed | ISI | ChemPort |
13. Clore, G.M. & Gronenborn, A.M. Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. Science 252, 1390−1399 (1991). | PubMed | ISI | ChemPort |
14. Bax, A. & Grzesiek, S. Methodological advances in protein NMR. Acc. Chem. Res. 26, 131−138 (1993). | ISI | ChemPort |
15. Grzesiek, S., Wingfield, P.T., Stahl, S.J., Kaufman, J.D. & Bax, A. Four-dimensional 15N-separated NOESY of slowly tumbling perdeuterated 15N-enriched proteins. Application to HIV-1 nef. J. Am. Chem. Soc. 117, 9594−9595 (1995). | ISI | ChemPort |
16. Grzesiek, S. & Bax, A. The importance of not saturating H2O in protein NMR. Application to sensitivity enhancement and NOE measurements. J. Am. Chem. Soc. 115, 12593−12594 (1993). | ISI | ChemPort |
17. Freund, J., Kellner, R., Houthaeve, T. & Kalbitzer, H.R. Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 221, 811−819 (1994). | PubMed | ISI | ChemPort |
18. Nilges, M., Clore, G.M. & Gronenborn, A.M. Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett 229, 317−324 (1988). | Article | PubMed | ISI | ChemPort |
19. Freund, J. et al. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223, 589−593 (1994). | PubMed | ISI | ChemPort |
20. Huang, Y., Zhang, L. & Ho, D.D. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69, 93−100 (1995). | PubMed | ISI | ChemPort |
21. Ramakrishna, V., Finch, J.T., Graziano, V., Lee, P.L. & Sweet, R.M. Crystal structure of globular domain of histone H5 and its implications for nucleosome binding. Nature 362, 219−223 (1993). | Article | PubMed | ISI | ChemPort |
22. Lim, W.A., Richards, F.M. & Fox, R.O. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375−379 (1994). | Article | PubMed | ISI | ChemPort |
23. Feng, S., Chen, J.K., Yu, H., Simon, J.A. & Schreiber, S.L. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science 266, 1241−1247 (1994). | PubMed | ISI | ChemPort |
24. Wu, X. et al. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215−226 (1995). | PubMed | ISI | ChemPort |
25. Studier, F.W., Rosenberg, A.H., Dunn, J.J. & Dubendorff, J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60−89 (1990). | PubMed | ChemPort |
26. Scharf, S.J., Horn, G.T. & Erlich, H.A. Direct cloning and sequence analysis of enzymatically amplified genomic sequences. Science 233, 1076−1078 (1986). | PubMed | ISI | ChemPort |
27. Holtzman, D.A., Cook, W.D. & Dunn, A.R. Isolation and sequence of a cDNA corresponding to a src-related gene expressed in murine hemopoietic cells. Proc. Natl. Acad. Sci. USA 84, 8325−8329 (1987). | PubMed | ChemPort |
28. Bax, A. et al. Measurement of homo- and heteronuclear J couplings from quantitative J correlation. Methods Enzymol. 239, 79−105 (1994). | Article | PubMed | ISI | ChemPort |
29. Brünger, A.T. XPLOR Version 3.1: A system for Crystallography and NMR, Yale University, New Haven, CT, USA (1992).
30. Garrett, D.S. et al. The impact of direct refinement against three-bond HN-CaH coupling constants on protein structure determination by NMR. J. Magn. Reson. B104, 99−103 (1994).
31. Kuszewski, J., Qin, J., Gronenborn, A.M. & Clore, G.M. The impact of direct refinement against proton chemical shifts in protein structure determination by NMR. J. Magn. Reson. B107, 293−297 (1995).
32. Carson, M. Ribbon models of macromolecules. J. Mol. Graphics 5, 103−106 (1987). | Article | ISI | ChemPort |
33. Nicholls, A, Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281−296 (1991). | PubMed | ISI | ChemPort |
34. Brooks, B.R. et al. CHARMM: a program for macromolecular energy minimization and dynamics calculations. J. Comput. Chem. 4, 187−217 (1983). | ISI | ChemPort |

	Top

	Top